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Abstract
Background: Although the fecal occult blood test (FOBT) is the preferred program for colorectal
cancer screening in Japan, many medical institutions have recently begun to provide total
colonoscopy (TCS) as an initial screening program. However, there are a number of severe risks
associated with TCS, such as colorectal bleeding and perforation. The justification for performing
such a procedure on healthy patients remains unclear. We used the analytic hierarchy process
(AHP) to investigate whether risk information on TCS affects patient preferences for colorectal
cancer screening.
Methods: We performed a questionnaire survey using an AHP decision-making model, targeting
285 people aged 40–59 years. We randomly assigned the subjects into Groups A (n = 146) and B
(n = 139). Both groups were provided with information on the effectiveness, cost and disadvantages
of the two screening programs. Group A was provided with additional information regarding the
risks of TCS. Individual priorities were calculated with pair-wise comparisons between the two
alternatives in each selection criteria. The influence of the risk information was analyzed using a
logistic regression analysis.
Results: The aggregated priorities in Group A for 'effectiveness', 'costs', and 'risks' were 0.603,
0.147, and 0.250, respectively, while those in Group B were 0.652, 0.149, and 0.199, respectively.
A logistic regression analysis showed that the provision of risk information significantly reduced the
subjects' priorities for TCS (p = 0.036).
Conclusion: The lack of risk information was related to the differences in priorities assigned to
effectiveness and risks of the two procedures. Patients must be well informed before making
decisions concerning their preferred colorectal cancer screening procedure.
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Background
In Japan, colorectal cancer is on the increase as a cause of
death [1]. Cancer screening is considered one of the most
promising approaches in the prevention of cancer deaths.
The fecal occult blood test (FOBT) is the preferred pro-
gram for colorectal cancer screening in Japan, being a non-
invasive, low-cost procedure. Subjects with positive FOBT
results are recommended to undergo total colonoscopy
(TCS), which is relatively invasive and costly; however,
FOBT has a number of limitations, including false nega-
tive and false positive results. Many hospitals in Japan
provide TCS to healthy individuals as an initial screening
program; however, there are a number of severe risks asso-
ciated with TCS, such as colorectal bleeding and perfora-
tion. The justification for performing such a procedure on
healthy patients remains unclear.
It is necessary to provide the general population with
appropriate information on cancer screening. The infor-
mation should focus on the risks as well as the effective-
ness and costs associated with various procedures. People
can then select their preferred service on the basis of all the
necessary information.
Although previous studies have examined patient prefer-
ences concerning colorectal cancer screening [2-6], there
is little agreement as to which test is more preferred.
Pignone et al. reported that patient preferences for color-
ectal cancer screening were sensitive to information
regarding test performance and cost information [6];
however, to our knowledge, the actual impact of risk
information on patient preferences remains unknown.
In the present study, we used the analytic hierarchy proc-
ess (AHP) to analyse peoples' preferences for colorectal
cancer screening. AHP is a flexible decision-making
method developed by Saaty in the 1970s [7] to help peo-
ple establish priorities and make the best decision, when
both the qualitative and quantitative aspects of a decision
need to be considered.
With regard to healthcare services, it appears to be some-
what difficult for physicians to communicate fair and suf-
ficient information to patients due to physician-specific
biases [8], limited diagnosis and treatment time [9], and
the limitations of physicians' interviewing skills [10].
AHP not only helps patients arrive at the best decision;, it
also provides a clear rationale by reducing complex deci-
sions to a series of one-on-one comparisons, thereafter
synthesizing the results. In the AHP model, the alternative
selection problem is structured into a hierarchy, with the
overall goal placed at the top, with lower-level selection
criteria below. Alternatives are then assigned weights at
each level of the hierarchy, and overall global weights and
priorities are obtained.
Several studies have considered the application of AHP in
medical decision-making [2,11-13]. The present study
aimed to use the AHP method to investigate whether risk
information affects people's preferences for colorectal
cancer screening procedures.
Methods
Construction of the AHP model
From the patient point of view, we constructed an AHP
decision model that helps people to make a dichotomous
choice between FOBT and TCS as an initial colorectal
screening program. We decomposed the decision prob-
lem into a hierarchy of more easily comprehended sub-
problems (Fig. 1). We focused on the following three cri-
teria related to decision-making in colorectal cancer
screening: 'effectiveness', 'costs', and 'disadvantages.'
The 'effectiveness' of the service is further divided into two
sub-criteria: 'mortality reduction rate' and 'cancer detec-
tion rate'.
The 'costs' are separated into two sub-criteria: 'out-of-
pocket payment' and 'time cost'. 'Time cost' represents the
indirect cost of the examination time at the expense of
working hours.
'Disadvantages' include 'false positives/negatives' and
'risks'. A false positive result can cause anxiety for the sub-
ject, whereas a false negative result can lead to delays in
diagnosis and treatment. The FOBT presents almost no
risk, while TCS can lead to complications such as bleeding
and perforation.
Subjects
This research was based on an Internet-based self-adminis-
tered questionnaire. We enlisted the services of an Internet
research company with approximately 261,000 registered
Internet users. We chose 640 males and females via strati-
fied random sampling from a total of approximately
79,000 persons aged 40–59 years.
The cover letter of the questionnaire clearly informed the
subjects that 1) data collection and analysis was completely
anonymous, ensuring that their private details would
remain confidential; 2) all the answers would be kept con-
fidential, processed statistically, and used only for scientific
study; and 3) they had a choice whether to participate or
not.
Our offer to the subjects to participate in our study was sent
by email on 19 December 2006. We obtained replies from
353 people within one week: a response rate of 55.2%.BMC Health Services Research 2008, 8:106 http://www.biomedcentral.com/1472-6963/8/106
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Questionnaire
We designed the FOBT and TCS information based on the
following evidence-based objective facts. In the present
study, FOBT means immunohistochemical test rather
than guaiac test.
(i) Mortality reduction rates
While several randomized controlled trials have evaluated
the mortality reduction rates of FOBT in Western nations,
there have been none in Japan. Data from case-control
studies are available for Japanese people: Saito et al.
reported that the estimated relative risk of mortality for
the screened population was 0.48 for FOBT [14].
To our knowledge, no data about mortality reduction
rates of TCS are available for Japanese people. Instead, we
referred to a foreign data based on a case-control study:
the estimated relative risk of mortality for the screened
population was 0.41 for TCS [15].
(ii) Cancer detection rates
In Japan, the cancer detection rate of FOBT is reportedly
27 per 10,000 persons, while that of TCS is 61 per 10,000
[16].
(iii) Out-of-pocket payment
The actual price of FOBT is less than ¥1,000 (about US$9)
or free, while that of TCS is ¥15,000–25,000 (US$130–
220).(unpublished data)
(iv) Time spent for TCS
Generally, in TCS, the use of a laxative in pre-treatment
requires approximately 2 hours; the actual examination
takes 10–15 minutes. Most colonoscopies in Japan are
done without sedation. In the present study, travel or
waiting time was not presented.
(v) False negatives/false positives
According to several studies, false negative rates are 7–
37% and 2–5% in FOBT and TCS, respectively. False pos-
itive rates in FOBT are 2–30%, while not reported in TCS
[17-21].
(vi) Complications
The risk of severe complications with TCS, including per-
foration and bleeding, has been reported to be approxi-
mately 8 per 10,000 colonoscopies without biopsy or
polypectomy [22]; FOBT poses almost no risk to the
patient.
The additional file 1 shows the "Information Sheet (orig-
inally in Japanese)" which was actually presented to the
participants. Two types of Information Sheets were pre-
pared, Sheets A and B. Sheet A included items (i)-(vi)
above, whereas Sheet B referred only to items (i)-(v),
excluding the risk information.
Sheet A was presented randomly to 176 respondents
(Group A) and Sheet B to 177 respondents (Group B).
Participants then answered a questionnaire based on the
AHP model, selecting one item from seven grades for a
pair-wise comparison of the factors and alternatives. That
is, for their judgement of relative importance between X
and Y variables, subjects were asked the following ques-
tions: "Which do you think is important, X or Y?" The
detailed illustrations with elements substituted for the X
and Y variables were as follows:
The decision-making model Figure 1
The decision-making model.
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Q1. Which do you think is important, 'effectiveness' or
'costs' from the point of choosing colorectal cancer screen-
ing?
Q2. Which do you think is important, 'effectiveness' or
'avoiding disadvantages' from the point of choosing
colorectal cancer screening?
Q3. Which do you think is important, 'costs' or 'avoiding
disadvantages' from the point of choosing colorectal can-
cer screening?
Q4. Which do you think is important, 'mortality reduc-
tion' or 'detection rate' from the point of effectiveness?
Q5. Which according to you is important 'co-payment' or
'time cost' from the point of costs?
Q6. Which do you think is important 'complications' or
'false-positives/false-negatives' from the point of avoiding
disadvantages?
Q7. Which do you think is important 'false-negatives' or
'false-positives' from the point of avoiding false-positives/
negatives?
The participants were requested to choose one answer to
each question from the following seven options:
1 X is extremely important.
2 X is strongly important.
3 X is moderately important.
4 Indifferent.
5 Y is moderately important.
6 Y is strongly important.
7 Y is extremely important.
Questions were also included on age, gender, concern
about their own health (3 grades: concerned a lot, con-
cerned a little, and not concerned), household annual
income, history of hospital admission and personal expe-
rience of FOBT and TCS.
Analysis
A consistency index (C.I.) was calculated for each
respondent, reflecting the consistency of qualitative judg-
ments of the importance of different criteria and the
impact of the importance on all comparisons [23]. If the
C.I. was less than 0.15, we assumed the comparison is
consistent [24]. In the present study, respondents with a
C.I. greater than or equal to 0.15 were excluded.
Individual priorities were calculated via pair-wise compar-
isons between the two alternatives in each selection crite-
ria. In the present study, we used geometric mean method
(GMM) to estimate individuals' relative weights of each
element. Aggregated weights of individual priorities were
calculated with GMM for synthesizing individual deci-
sions into a group decision [9]. To derive the group
weights for each element, we calculated geometric mean
from each individual pair-wise comparison matrix. For all
these calculations, we used a programmed spreadsheet
established with Microsoft Excel™ software.
We analysed the influence of the risk information on the
subjects' decisions using a logistic regression analysis; the
results of the dichotomous choice between FOBT and TCS
were regressed against a variety of independent variables
including the type of information presented and the sub-
jects' backgrounds.
We used the statistical software JMP version 6.0.3 (SAS
Institute Inc., Cary, NC, USA) for all statistical analyses. A
p value less than 0.05 was considered to be statistically
significant.
Results
Baseline characteristics
Sixty-eight respondents with a C.I. greater than or equal to
0.15 were excluded, leaving a total of 285 respondents to
be analysed. The proportion of inconsistent respondents
was 19% (= 68/353). The participants' characteristics of
both consistent and inconsistent subjects are shown in
Table 1. In the consistent subjects, the average (± SD) of
consistency index values were 0.058 ± 0.052 in Group A
(n = 146) and 0.063 ± 0.051 in Group B (n = 139).
Aggregated weights and priorities
Table 2 shows the global and local priorities and weights
of each subcriteria, as well as overall priorities. The aggre-
gated priorities in Group A for 'effectiveness', 'costs', and
'avoiding disadvantages' were 0.603, 0.147 and 0.250,
respectively, while those in Group B were 0.652, 0.149,
and 0.199, respectively. That is, Group A represented a
higher priority to 'avoiding disadvantage' and a lower pri-
ority to 'effectiveness' compared to Group B. Overall pri-
orities of TCS were 0.620 and 0.652 in Group A and
Group B, respectively.
Individual weights and priorities
In Group B, 124 (89.2%) of the 146 respondents gave a
higher priority to TCS than to FOBT; in Group A, 118
(80.8%)/139 preferred TCS to FOBT. These two figures
differ significantly. (p < 0.01)BMC Health Services Research 2008, 8:106 http://www.biomedcentral.com/1472-6963/8/106
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In the logistic regression analysis, 'type of information'
was a significant factor affecting choice between FOBT
and TCS (Table 3): those presented with the risk informa-
tion concerning TCS were more likely to choose FOBT.
Discussion
People's preferences for colorectal cancer screening
Cancer screening exists to save lives. In order to reduce
overall morbidity and mortality of cancer, it would be
important to increase the participation rate of screening
program. Several previous studies indicated that use of
"decision-aid" significantly increased the participation
rate of colorectal cancer screening [26,27]. AHP can be uti-
lized as a tool for decision aid.
In the present study, we found that fewer subjects
expressed a preference for FOBT than for TCS. The subjects
placed the greatest weighting on 'effectiveness'. This result
indicates that their greatest concern about cancer screen-
ing is the life-saving effect.
The relative weight of avoiding the risks of TCS was much
smaller than that of its effectiveness. In other words, many
people seemed to consider the risks associated with TCS to
be small, and did not attach much importance to them:
instead, subjects focused on the life-saving aspect of TCS.
Subjects had relatively little concern about the costs of
screening. Possibly, the costs of TCS were inconsiderable
and affordable to them.
Necessity of informed consent
Priority of 'effectiveness' was higher in Group B (0.652)
than in Group A (0.603), while priority of 'avoid disad-
vantage' was lower in Group B (0.250) than in Group A
(0.199). That is, lack of risk information regarding perfo-
ration and bleeding increased weight of 'effectiveness' and
decreased weight of 'avoid disadvantages'.
It is necessary to provide the general population with suf-
ficient information on colorectal cancer screening. Such
information should include not only the effectiveness but
also the risks of screening.
Davey et al. reported that most women wanted informa-
tion about the possibility of false results and side effects;
although such information would make them anxious,
they wanted it anyway [25]. However, it is thought that
many healthcare professionals and the media tend only to
focus on the effectiveness of the screening. Ideally, people
should be well informed before making decisions affect-
ing their health; unfortunately, most are ill-informed with
regard to screening.
In the present study, the provision of the risk information
changed the preferred screening method for 8.4% of the
subjects. The priority for TCS in Group B can be regarded
as an overestimation due to a lack of information. How-
ever, >80% of the subjects in Group A still preferred TCS
in spite of the provision of risk information. These results
Table 1: Sample Characteristics (n = 353)
Parameters Included subjects (n = 285) Excluded subjects (n = 68)
Group A (n = 146) Group B (n = 139) Group A (n = 30) Group B (n = 38)
Sex
Male 71 (49%) 63 (45%) 16 (53%) 23 (61%)
Female 75 (51%) 76 (55%) 14 (47%) 15 (39%)
Age (average ± SD) 48.6 ± 6.0 48.7 ± 5.4 50.1 ± 5.8 48.2 ± 5.3
Concerns about own health
Concerned a lot 58 (40%) 46 (33%) 10 (33%) 11 (29%)
Concerned a little 50 (34%) 53 (38%) 12 (40%) 19 (50%)
Not concerned at all 38 (26%) 40 (29%) 8 (27%) 8 (21%)
Annual household income
Low (<US$59,999) 35 (24%) 46 (33%) 12 (40%) 14 (37%)
Medium (US$60,000 – 119,999) 76 (52%) 58 (42%) 13 (43%) 17 (45%)
High (>US$120,000) 14 (10%) 11 (8%) 3 (10%) 3 (8%)
No answer given 21 (14%) 24 (17%) 2 (7%) 4 (11%)
Experience of hospital admission
None 52 (36%) 54 (39%) 16 (53%) 10 (26%)
1 admission 43 (29%) 31 (22%) 5 (17%) 9 (24%)
2 admissions 22 (15%) 31 (22%) 6 (20%) 10 (26%)
3 or more admissions 26 (18%) 22 (16%) 3 (10%) 8 (21%)
No answer given 3 (2%) 1 (1%) 0 (0%) 1 (3%)
Experience of FOBT: Yes 83 (57%) 81 (58%) 20 (67%) 23 (61%)
Experience of TCS: Yes 24 (16%) 30 (22%) 8 (27%) 5 (13%)BMC Health Services Research 2008, 8:106 http://www.biomedcentral.com/1472-6963/8/106
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suggest that many people can balance the concerns of dis-
advantages against the effectiveness of saving lives.
Limitations of the present study
In the present study, several limitations should be
acknowledged.
First, we chose our subjects from Internet users in Japan.
Although approximately 80% of Japanese homes now
have access to the Internet, Internet users as a group may
be biased toward those with higher levels of education
and higher annual incomes. The second limitation is the
self-selection bias. Third, the model we used did not con-
Table 2: Results of comparison between FOBT and TCS (aggregated weights and priorities)
Criterion Group A Group B
Global priority Local priority FOBT weight TCS weight Global priority Local priority FOBT weight TCS weight
Major criteria
Effectiveness 0.603 0.220 0.780 0.652 0.202 0.798
Costs 0.147 0.830 0.170 0.149 0.839 0.161
Avoid 
disadvantages
0.250 0.501 0.499 0.199 0.455 0.545
Subcriteria of 
'effectiveness'
Mortality 
reduction rates
0.393 0.652 0.237 0.763 0.471 0.723 0.225 0.775
Detection rates 0.210 0.348 0.187 0.813 0.181 0.277 0.192 0.808
Subcriteria of 'costs'
Time cost 0.071 0.482 0.828 0.172 0.071 0.479 0.817 0.183
Out-of-pocket 
payment
0.076 0.518 0.832 0.168 0.078 0.521 0.832 0.168
Subcriteria of 'avoid 
disadvantages'
Complications 0.163 0.650 0.670 0.330 0.092 0.461 0.790 0.210
False positives/
negatives
0.088 0.250 0.185 0.815 0.107 0.539 0.168 0.832
Subcriteria of 'avoid 
false positives/
negatives'
False positives 0.062 0.706 0.186 0.814 0.076 0.711 0.180 0.820
False negatives 0.026 0.294 0.182 0.818 0.031 0.289 0.177 0.823
Global priority of each subcriterion = local priority of each subcriterion * priority of the parent criterion. e.g., global priority of mortality reduction 
rates in Group A = 0.652*0.603 = 0.393.
Weight of the parent criterion is the sum of (weight * local priority) of each subcriterion. e.g., FOBT weight of effectiveness in Group A = 
0.237*0.652+0.187*0.348 = 0.220.
Overall priority is the sum of (weight * local priority) of each major criterion.
Overall priority of FOBT in Group A = 0.220*0.603+0.830*0.147+0.501*0.250 = 0.380.
Overall priority of TCS in Group A = 0.780*0.603+0.170*0.147+0.499*0.250= 0.620.
Overall priority of FOBT in Group B = 0.202*0.652+0.839*0.149+0.455*0.199= 0.348.
Overall priority of TCS in Group B = 0.798*0.652+0.161*0.149+0.545*0.199 = 0.652.
Table 3: Logistic regression analysis (1: FOBT, 0: TCS)
Independent variables Odds ratio 95% confidence interval P value
Group (A: 1, B: 0) 0.443 0.200–0.931 0.036
Sex (male: 1, female: 0) 1.398 0.681–2.915 0.364
Age 1.018 0.301–3.405 0.977
Concerns about own health 1.438 0.347–5.582 0.605
Annual household income 0.693 0.141–3.377 0.649
Experience of hospital admission 2.073 0.786–5.485 0.139
Experience of FOBT (Yes: 1, No: 0) 2.202 1.001–5.041 0.054
Experience of TCS (Yes: 1, No: 0) 1.370 0.427–5.308 0.616
R2 = 0.690BMC Health Services Research 2008, 8:106 http://www.biomedcentral.com/1472-6963/8/106
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sider effect of polyp detection. One of the objectives of
colorectal cancer screening programs is to identify and
remove potentially pre-cancerous polyps. Fourth, several
data presented were only estimates with broad ranges. It is
possible that use of different estimates could have affected
the study results. Fifth, the subjects' reactions to the infor-
mation, especially disadvantages, could have been
affected by the way the information was formatted. Sixth,
excluding the inconsistent subjects could be a limitation
because of unequal characteristics between the consistent
and inconsistent groups. Although statistically insignifi-
cant, the male ratio was substantially high in the incon-
sistent group. Seventh, the local priorities of the
'effectiveness' sub-criterion differed between Group A and
B, although they should be similar because there was no
difference in the information presented. This disparity
may have been caused by the inequality of the distribu-
tion of participants' characteristics, particularly the differ-
ence of concerns about their own health.
Conclusion
In the present study, we investigated whether risk infor-
mation affects people's preferences to colorectal cancer
screening using AHP. The results suggest that there is a
relationship between the lack of risk information and the
differences in priorities assigned to effectiveness and risks
of the two procedures. Patients should be well informed
of both the risks and benefits before making decisions on
selecting colorectal cancer screening options.
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